1. Development of everolimus, a novel oral mTOR inhibitor, across a spectrum of diseases. (9th May 2013) Authors: Lebwohl, David; Anak, Özlem; Sahmoud, Tarek; Klimovsky, Judith; Elmroth, Ingrid; Haas, Tomas; Posluszny, Joseph; Saletan, Stephen; Berg, William Journal: Annals of the New York Academy of Sciences Issue: Volume 1291(2013) Page Start: 14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Estimation of COVID-19 burden in Egypt. Issue 8 (August 2020) Authors: Sahmoud, Tarek Journal: Lancet infectious diseases Issue: Volume 20:Issue 8(2020) Page Start: 895 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Health-related quality of life and disease symptoms in postmenopausal women with HR+, HER2− advanced breast cancer treated with everolimus plus exemestane versus exemestane monotherapy. (November 2013) Authors: Campone, Mario; Beck, J. Thaddeus; Gnant, Michael; Neven, Patrick; Pritchard, Kathleen I.; Bachelot, Thomas; Provencher, Louise; Rugo, Hope S.; Piccart, Martine; Hortobagyi, Gabriel N.; Nunzi, Martina; Heng, Daniel Y.C.; Baselga, José; Komorowski, Anna; Noguchi, Shinzaburo; Horiguchi, Jun; Bennet... Journal: Current medical research and opinion Issue: Volume 29:Number 11(2013:Nov.) Page Start: 1463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Health‐related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO‐2 trial12. Issue 10 (15th March 2013) Authors: Burris, Howard A.; Lebrun, Fabienne; Rugo, Hope S.; Beck, J. Thaddeus; Piccart, Martine; Neven, Patrick; Baselga, Jose; Petrakova, Katarina; Hortobagyi, Gabriel N.; Komorowski, Anna; Chouinard, Edmond; Young, Robyn; Gnant, Michael; Pritchard, Kathleen I.; Bennett, Lee; Ricci, Jean‐Francois; Bauly... Journal: Cancer Issue: Volume 119:Issue 10(2013) Page Start: 1908 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Health‐related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO‐2 trial12. Issue 10 (15th March 2013) Authors: Burris, Howard A.; Lebrun, Fabienne; Rugo, Hope S.; Beck, J. Thaddeus; Piccart, Martine; Neven, Patrick; Baselga, Jose; Petrakova, Katarina; Hortobagyi, Gabriel N.; Komorowski, Anna; Chouinard, Edmond; Young, Robyn; Gnant, Michael; Pritchard, Kathleen I.; Bennett, Lee; Ricci, Jean‐Francois; Bauly... Journal: Cancer Issue: Volume 119:Issue 10(2013) Page Start: 1908 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗